Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP265527.RAxYzvsXFEAyxuzxW5BDwiYVug9RVvCPn_RX6cC6GiW_Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP265527.RAxYzvsXFEAyxuzxW5BDwiYVug9RVvCPn_RX6cC6GiW_Y130_assertion type Assertion NP265527.RAxYzvsXFEAyxuzxW5BDwiYVug9RVvCPn_RX6cC6GiW_Y130_head.
- NP265527.RAxYzvsXFEAyxuzxW5BDwiYVug9RVvCPn_RX6cC6GiW_Y130_assertion description "[Because no data are available on the involvement of the plasmin activation system in matrix degradation by thyroid carcinoma, the present study was performed using follicular thyroid carcinoma cell lines obtained from a primary tumor (FTC-133) and metastases (FTC-236 and FTC-238) of one patient.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265527.RAxYzvsXFEAyxuzxW5BDwiYVug9RVvCPn_RX6cC6GiW_Y130_provenance.
- NP265527.RAxYzvsXFEAyxuzxW5BDwiYVug9RVvCPn_RX6cC6GiW_Y130_assertion evidence source_evidence_literature NP265527.RAxYzvsXFEAyxuzxW5BDwiYVug9RVvCPn_RX6cC6GiW_Y130_provenance.
- NP265527.RAxYzvsXFEAyxuzxW5BDwiYVug9RVvCPn_RX6cC6GiW_Y130_assertion SIO_000772 10524570 NP265527.RAxYzvsXFEAyxuzxW5BDwiYVug9RVvCPn_RX6cC6GiW_Y130_provenance.
- NP265527.RAxYzvsXFEAyxuzxW5BDwiYVug9RVvCPn_RX6cC6GiW_Y130_assertion wasDerivedFrom befree-2016 NP265527.RAxYzvsXFEAyxuzxW5BDwiYVug9RVvCPn_RX6cC6GiW_Y130_provenance.
- NP265527.RAxYzvsXFEAyxuzxW5BDwiYVug9RVvCPn_RX6cC6GiW_Y130_assertion wasGeneratedBy ECO_0000203 NP265527.RAxYzvsXFEAyxuzxW5BDwiYVug9RVvCPn_RX6cC6GiW_Y130_provenance.